From Name:
From Email:
To Name:
To Email:

Optional Message:

PET imaging quantifying 68Ga-PSMA-11 uptake in metastatic colorectal cancer

from The Journal of Nuclear Medicine

At diagnosis 22% of colorectal cancer patients have metastases and 50% later develop metastasis. Peptide receptor radionuclide therapy with lutetium-177 (177Lu)-PSMA-617 is employed to treat metastatic prostate cancer. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063